Circ_0007385 Served As Competing Endogenous RNA for MiR-519d-3p to Suppress Malignant Behaviors and Cisplatin Resistance of Non-small Cell Lung Cancer Cells
Overview
Pulmonary Medicine
Affiliations
Background: Circular RNAs (circRNAs) have been closely implicated in competing endogenous RNA (ceRNA) network among human cancers including non-small cell lung cancer (NSCLC). However, the role of most circRNAs in NSCLC remains to be determined. Here, we aimed to investigate the role of hsa_circ_0007385 (circ_0007385) in NSCLC cells.
Methods: Expression of hsa_circ_0007385 (circ_0007385), miRNA (miR)-519d-5p and high-mobility group box 1 (HMGB1) was measured by real-time quantitative PCR and western blotting. Functional experiments were evaluated by cell counting kit (CCK)-8, flow cytometry, fluorescein active caspase-3 staining kit, transwell assays, western blotting, and xenograft experiment. The relationship among circ_0007385,miR-519d-5p and HMGB1 was testified by dual-luciferase reporter assay. Kaplan-Meiersurvival curve identified overall survival in NSCLC patients.
Results: circ_0007385 expression was higher in NSCLC tissues and cell lines, and was associated with poor overall survival. Silencing circ_0007385 could suppress cell proliferation, migration and invasion in A549 and H1975 cells, as well as cisplatin (DDP) resistance. Moreover, circ_0007385 silence retarded tumor growth of A549 cells in vivo. Molecularly, there was a direct interaction between miR-519d-3p and either circ_0007385 or HMGB1; expression of miR-519d-3p was downregulated in NSCLC tumors in a circ_0007385-correlated manner, and circ_0007385 could indirectly regulate HMGB1 via miR-519d-3p. Functionally, both inhibiting miR-519d-3p and restoring HMGB1 could overturn the suppressive effect of circ_0007385 knockdown on cell proliferation, migration, invasion, and DDP resistance.
Conclusions: Collectively, circ_0007385 deletion could function anti-tumor role in NSCLC by suppressing malignant behaviors and DDP resistance in vitro and in vivo via circ_0007385/miR-519d-3p/HMGB1 axis. These outcomes might enhance our understanding of the molecular mechanisms underlying the malignant progression of NSCLC.
Key Points: SIGNIFICANT FINDINGS OF THE STUDY: circ_0007385 was upregulated in NSCLC tissues and cells, and was associated with poor overall survival. Silenced circ_0007385 suppressed NSCLC cell proliferation, migration, invasion, and DDP resistance in vitro, and tumor growth in vivo. circ_0007385 was upregulated in NSCLC tissues and cells, and was associated with poor overall survival.
What This Study Adds: miR-519d-3p could directly interact with circ_0007385 and HMGB1 in NSCLC cells. A promising circ_0007385/miR-519d-3p/HMGB1 regulatory pathway was determined in NSCLC cells.
[Predictive Value of A miRNA Signature for Distant Metastasis in Lung Cancer].
Cong J, Wang A, Wang Y, Li X, Pi J, Liu K Zhongguo Fei Ai Za Zhi. 2025; 27(12):919-930.
PMID: 39962847 PMC: 11839496. DOI: 10.3779/j.issn.1009-3419.2024.102.43.
The modulation of immune cell death in connection to microRNAs and natural products.
Chuang Y, Yen C, Tang J, Chang F, Tsai Y, Wu K Front Immunol. 2025; 15:1425602.
PMID: 39759512 PMC: 11695430. DOI: 10.3389/fimmu.2024.1425602.
Circular RNAs in lung cancer: implications for preventing therapeutic resistance.
Liu W, Sun Y, Huo Y, Zhang L, Zhang N, Yang M EBioMedicine. 2024; 107:105309.
PMID: 39191172 PMC: 11445705. DOI: 10.1016/j.ebiom.2024.105309.
Identification of Circular RNAs as Biomarker Candidates in Lung Cancer Treatment.
Apaydin B, Mert U, Asadi M, Muftuoglu C, Caner A Asian Pac J Cancer Prev. 2024; 25(6):2147-2157.
PMID: 38918678 PMC: 11382869. DOI: 10.31557/APJCP.2024.25.6.2147.
Yang X, Du Y, Luo L, Xu X, Xiong S, Yang X Int J Mol Sci. 2023; 24(18).
PMID: 37762212 PMC: 10530696. DOI: 10.3390/ijms241813909.